Analystreport

Globus Medical, Inc. (NYSE: GMED) had its "sell" rating re-affirmed by analysts at Barclays PLC. They now have a $28.00 price target on the stock.

Globus Medical, Inc. Class A  (GMED) 
Last globus medical, inc. class a earnings: 2/20 04:15 pm Check Earnings Report
US:NYSE Investor Relations: investors.globusmedical.com